Amalgamated Bank Reata Pharmaceuticals Inc Transaction History

Amalgamated Bank

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$79.22 - $105.37 $78,982 - $105,053	-997 Reduced 26.56%	2,757 $281,000
Q1 2023 May 02, 2023	SELL	$30.85 - $93.17 $15,702 - $47,423	-509 Reduced 11.94%	3,754 $341,000
Q3 2022 Nov 09, 2022	BUY	$19.41 - $36.49 $1,086 - $2,043	56 Added 1.33%	4,263 $107,000
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $2,298 - $4,051	-111 Reduced 2.57%	4,207 $128,000
Q1 2022 Jun 30, 2022	SELL	$24.12 - $39.6 $9,575 - $15,721	-397 Reduced 8.42%	4,318 $141,000
Q3 2021 Oct 29, 2021	SELL	$100.0 - $143.02 $29,600 - $42,333	-296 Reduced 5.91%	4,715 $474,000
Q2 2021 Aug 16, 2021	BUY	$78.27 - $151.29 $25,594 - $49,471	327 Added 6.98%	5,011 $709,000
Q1 2021 May 13, 2021	BUY	$94.25 - $132.81 $1,885 - $2,656	20 Added 0.43%	4,684 $467,000
Q4 2020 Feb 12, 2021	SELL	$102.03 - $184.62 $408 - $738	-4 Reduced 0.09%	4,664 $576,000
Q3 2020 Oct 30, 2020	SELL	$93.53 - $163.34 $3,741 - $6,533	-40 Reduced 0.85%	4,668 $455,000
Q2 2020 Aug 10, 2020	BUY	$126.3 - $176.56 $120,995 - $169,144	958 Added 25.55%	4,708 $735,000
Q1 2020 May 13, 2020	SELL	$124.16 - $247.74 $14,402 - $28,737	-116 Reduced 3.0%	3,750 $541,000
Q4 2019 Feb 13, 2020	BUY	$74.57 - $217.92 $49,439 - $144,480	663 Added 20.7%	3,866 $790,000
Q3 2019 Nov 13, 2019	SELL	$71.26 - $95.75 $3,563 - $4,787	-50 Reduced 1.54%	3,203 $257,000
Q2 2019 Aug 14, 2019	BUY	$77.72 - $94.35 $25,025 - $30,380	322 Added 10.99%	3,253 $307,000
Q1 2019 May 15, 2019	BUY	$51.9 - $101.79 $152,118 - $298,346	2,931 New	2,931 $251,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.